Cytospire
cytospire.com
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer
Read more
Report
$83M to Unlock a New Generation of Cancer Immunotherapies - Cytospire Therapeutics Ltd - OncoDaily
$83M to Unlock a New Generation of Cancer Immunotherapies - Cytospire Therapeutics Ltd / cancer, cancer immunotherapies, Cytospire Therapeutics Ltd,
Read more
Report
4BIO Capital leads oversubscribed £61 million ($83m) Series A financing of Cytospire Therapeutics
4BIO Capital joined by new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and LifeArc VenturesCytospire's novel pan-gamma T cell engagers offer a compelling soluti
Read more
Report
Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures,...
Read more
Report